1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
Turnaround Potential
133.51 4.77 (3.71%)
58.51% Gain from 52W Low
1.3M
XNAS Volume

XNAS 09 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share

Detailed Stock Analysis for Neurocrine Biosciences, Inc. with Real-time Stock Report

crown icon
Premium Feature
Please subscribe to Pro or ProPlus
Subscribe Sign in